Export Incentives Coupled with Domestic Disincentives

The People’s Republic of China has moved to shut down the domestic marketing of wild animals on fears [wild animal traders’] goods sparked the coronavirus pandemic. This is a seeming response to growing international pressure on the PRC to cut that out for that reason.

[The People’s Republic of] China’s National People’s Congress on February 24 imposed a ban on the sale and consumption of wild animals in the country.


Less than a month later, [The People’s Republic of] China’s Ministry of Finance and tax authority said on March 17 they would raise value-added tax rebates on nearly 1,500 Chinese products, including offering a 9% rebate on the export of animal products such as edible snakes and turtles, primate meat, beaver and civet musk, and rhino horns….

As the Congressional Research Service, cited in the article at the link, mentioned, the export move

could spread the risk to global markets[.]

You think?

The CRS’ report further noted,

Absent in [The People’s Republic of] China’s policy push are incentives to encourage the sale of pharmaceuticals, PPE, and other medical products overseas[.]

Hmm. Makes me wonder just what the PRC is up to, really.


The CRS’ report can be read here.

Leave a Reply

Your email address will not be published. Required fields are marked *